Health
AstraZeneca COVID-19 shot candidate shows promise among elderly in trials – Reuters
A potential COVID-19 vaccine developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, giving hope it may protect some…
LONDON, Nov 19 (Reuters) – A potential COVID-19 vaccine developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, giving hope it may protect some of those most vulnerable to the disease, data from mid-stage trials showed.
The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70 – who are at higher risk of serious illness and death from COVID-19 – could build robust immunity to…
Continue Reading
